Supernus Pharmaceuticals, Inc. Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.11M0.80M1.48M12.02M92.68M147.47M215.00M302.24M408.90M392.75M520.40M579.77M667.24M607.52M661.82M
Cost of Revenue 1.10M5.76M8.42M11.99M15.21M15.36M16.66M52.46M75.06M87.22M83.78M77.91M
Gross Profit 10.91M86.92M139.04M203.02M287.02M393.54M376.10M467.94M504.71M580.02M523.74M583.91M
Operating items
Amortization - Intangibles 5.20M5.20M15.70M30.00M82.63M82.40M78.00M
Research & Development 35.15M30.63M23.52M17.25M19.59M29.14M42.79M49.58M89.21M69.10M75.96M90.47M74.55M91.59M108.80M
Selling, General & Administrative 5.08M7.93M20.13M55.59M72.61M89.06M106.01M137.91M154.70M153.25M200.68M304.76M377.22M336.36M321.58M
Other Operating Expenses 1.10M5.76M8.42M11.99M15.21M20.55M21.84M70.06M98.52M169.34M184.84M149.77M
Operating Expenses 40.23M38.55M43.65M73.94M97.96M126.62M160.79M202.70M264.45M244.18M346.70M493.75M621.11M612.79M580.15M
Operating Income -40.12M-37.75M-42.17M-61.92M-5.28M20.84M54.22M99.54M144.44M148.57M173.70M86.03M46.12M-5.27M81.67M
EBIT -40.12M-37.75M-42.17M-61.92M-5.28M20.84M54.22M99.54M144.44M148.57M173.70M86.03M46.12M-5.27M81.67M
Non-operating items
Non Operating Investment Income -0.09M-0.71M-13.35M2.81M0.19M0.45M0.08M
Interest & Investment Income 0.11M0.03M0.12M0.30M0.35M0.68M1.47M2.86M13.84M
Other Non Operating Income 0.54M0.20M0.05M-9.55M-2.59M-2.34M0.71M2.65M13.84M21.62M18.70M-12.85M21.69M10.45M16.20M
Non Operating Income 0.65M-1.72M-4.12M-30.35M-5.02M-6.23M-3.85M1.08M-4.27M-1.08M-5.05M-12.85M21.69M10.45M16.20M
Net income details
EBT -39.47M-39.47M-46.28M-92.27M-10.29M14.61M50.37M100.62M140.18M147.49M168.65M73.17M60.74M2.77M97.87M
Tax Provisions -0.40M-16.25M0.63M0.67M-40.85M43.33M29.18M34.43M41.70M19.75M0.03M1.45M24.00M
Profit After Tax -39.08M53.81M-46.28M-92.27M-10.93M13.94M91.22M57.28M110.99M113.06M126.95M53.42M60.71M1.32M73.86M
Income from Continuing Operations -39.08M-23.23M-46.28M-92.27M-10.93M13.94M91.22M57.28M110.99M113.06M126.95M53.42M60.71M1.32M73.86M
Consolidated Net Income 0.61M77.04M-46.28M-92.27M-10.93M13.94M91.22M57.28M110.99M113.06M126.95M53.42M60.71M1.32M73.86M
Income towards Parent Company 0.61M77.04M-46.28M-92.27M-10.93M13.94M91.22M57.28M110.99M113.06M126.95M53.42M60.71M1.32M73.86M
Preferred Dividend Payments 3.43M3.43M1.14M
Net Income towards Common Stockholders -41.89M50.38M-47.43M-92.27M19.87M13.94M91.22M57.28M110.99M113.06M126.95M53.42M60.71M1.32M73.86M
Additional items
EPS (Basic) -26.7731.39-2.72-2.90-0.260.291.841.132.132.162.411.011.130.021.34
EPS (Weighted Average and Diluted) -26.382.34-2.72-2.90-0.260.281.761.082.052.102.360.981.040.021.32
Shares Outstanding (Weighted Average) 24.91M24.53M33.84M42.93M48.92M49.51M51.26M52.26M52.46M52.69M53.18M54.06M54.63M55.22M
Shares Outstanding (Diluted Average) 1.59M1.61M17.44M53.30M54.10M53.82M53.69M54.36M61.68M55.51M55.96M
EBITDA -40.12M-37.75M-42.17M-61.92M-5.28M20.84M54.22M99.54M144.44M148.57M173.70M86.03M46.12M-5.27M81.67M
Interest Expenses 1.87M3.58M7.85M4.96M1.23M0.54M1.57M18.11M22.71M23.75M23.42M7.07M2.42M
Tax Rate 1.01%41.16%4.56%43.07%20.82%23.35%24.72%26.99%0.05%52.47%24.53%